Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutraceutical Discoveries and Attitude Drinks sign partnership agreement
Innutria is said to be a specific blend of naturally occurring nutrients designed to be added to foods or beverages. After many years of thorough, scientific study and
Innutria is said to be a specific blend of naturally occurring nutrients designed to be added to foods or beverages. After many years of thorough, scientific study and
The product will be launched immediately in more than 20,000 retail outlets under the trademark Coldizin24, at a very low risk for Scandinavian Clinical Nutrition (SCN), and with
MDP 301 is a multi-national, randomized, double-blind, placebo-controlled Phase III trial designed to examine the safety and effectiveness of PRO 2000 in preventing HIV infection in women. The
The court had previously granted a joint request by the parties to stay all proceedings in the case, including the Markman claims construction hearing (previously scheduled for June
By combining the product offerings under one company name, Q Pharma expects to better leverage the variety of services offered within the three organizations and also pass along
OGX-011 is currently completing five Phase II clinical studies in prostate, lung and breast cancer, and is designed to inhibit the production of a specific protein, clusterin, associated
Dr Ma will report directly to Shuhui Chen, chief scientific officer of WuXi PharmaTech. Dr Ma has received his PhD in organic chemistry from the University of Tokushima,
The registry is open to all phenylketonuria (PKU) clinics within the US, and all patients screened for Kuvan responsiveness are eligible for enrollment in the registry. Also, from
The Francis trial is designed to assess the impact of oral varespladib on known biological markers of cardiovascular risk. It will enroll up to 500 patients that will
Paul Lisenby, CEO of XTend Medical, said: “Once the FDA has cleared the device for sale, we will immediately begin marketing the product to our managed care companies